Over the past decade, flow cytometry has undergone transformative advancements, notably with the adoption of spectral flow cytometry and the emergence of next-generation imaging cytometers.
As the incidence of cancer rises around the world, the demand for faster, more precise diagnoses is also on the rise. This demand will only intensify over time, as the worldwide incidence of cancer is ...
This technology has vast potential to help patients but remains underutilized and underappreciated. The tools are there. What’s lacking are harmonized controls, regulatory guidelines and database ...
Fluorescence-activated flow cytometry is one of the most powerful technologies that is routinely used in immunology. It allows not only for the rapid multiparametric analysis of cells on a ...
The Invitrogen™ Attune™ CytPix Flow Cytometer can simultaneously collect fluorescence data and high-resolution brightfield images of individual cells. This allows to better understand the morphology ...
Background Eosinophilic oesophagitis (EoE) is a chronic allergic disease characterised by oesophageal epithelial remodelling, barrier dysfunction and inflammation. The transcription factor forkhead ...
Background Globally, an estimated 296 million individuals live with chronic hepatitis B virus (HBV) infection, carrying ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
Hosted on MSN
Bullish flow in Tesla with shares up 3.77%
Bullish flow in Tesla (TSLA), with shares up $16.59, or 3.77%, near $456.69. Options volume running well above average with 3.46m contracts traded and calls leading puts for a put/call ratio of 0.72, ...
A little more than a year ago, on a trip to Nairobi, Kenya, some colleagues and I met a 12-year-old Masai boy named Richard Turere, who told us a fascinating story. His family raises livestock on the ...
Hosted on MSN
Bullish flow in Rocket Lab USA with shares up 2.49%
Bullish flow in Rocket Lab USA (RKLB), with shares up $1.58, or 2.49%, near $65.33. Options volume relatively light with 17k contracts traded and calls leading puts for a put/call ratio of 0.4, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback